Wright State biomed engineering students aim to improve prosthetics for injured veterans

A team of Wright State University student researchers is determined to make artificial limbs more comfortable and, consequently, more useful. The students are working on a new design they hope to someday test at the Dayton VA Medical Center, which has 500 hospital beds and provides a full range of health care to veterans.

Tarun Goswami, joint associate professor of biomedical engineering and orthopaedic surgery at Wright State, is helping guide the research. He also heads the university’s Device Development Center.

His students learned about common prosthetic problems by speaking to a few amputees at the Dayton VA.

“When talking to the patients, there were some expectations that they really wanted us to focus on,” said student researcher Paige King. “A lot of it had to do with temperature control. Whenever they were really active, they would experience a lot of moisture that would build up in the liner.”

King said patients also wanted improvements in the skin-rubbing edges of the socket and a self-adjusting feature to minimize clinic visits for refittings.

The students’ research has led to ideas, which they have shared with VA officials and Gene McQuinn, president of PSMCo, a Dayton company positioned to produce any device designed by the students.

The researchers said they may create a design that incorporates a number of the temperature-control ideas and other improvements. They hope to file for patents and produce a prototype that can be tested.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Norwood Medical in Dayton planning $13.5M expansion, adding 50 jobs | Dayton Business Journal, September 17, 2014

Youngstown Business Incubator and TechColumbus 1st and 3rd university associated incubators in the world | UBI Index, September 16, 2014

Enable Injections featured in article on safer, simpler, smarter devices for drug delivery | Drug Development & Delivery, September 15, 2014

BioOhio takes 2014 Annual Conference “on the road” in series of three regional events | Business Wire, September 15, 2014

ABC’s of IND’s – ChanTest to Host Session at the Safety Pharmacology Society (SPS) Annual Meeting | PR Web, September 15, 2014

Nationwide Children’s Hospital discusses Enterovirus D68 | Nationwide Children's Hospital, September 12, 2014

Akebia Therapeutics (NASDAQ: AKBA) to ring the NASDAQ Stock Market Opening Bell | NASDAQ, September 11, 2014

$1M grant to Cincinnati Children’s intended to improve human growth and development around the world | CCHMC, September 10, 2014

Airway Therapeutics gets money to advance treatment for smallest and sickest babies | WCPO9 Cincinnati, September 10, 2014

Airway Therapeutics raises $4.6M in Series A financing | CincyTech, September 10, 2014

Airway Therapeutics announces $4.6M funding round | Cincinnati.com, September 10, 2014

Alkermes anti-addiction drug Vivitrol helping inmates at Barnstable County Correctional Facility (MA) | Boston Business Journal, September 8, 2014

Nationwide Children’s Hospital now home to the world’s largest Ronald McDonald House | Columbus Dispatch, September 8, 2014

Envision Pharmaceutical completes its acquisition of MedTrak Services (Kansas) | Herald Online, September 8, 2014

Ohio Capital Fund key player in state startup scene | Cincinnati.com, September 6, 2014

Navidea enters Lymphoseek development and commercialization agreement with Hainan Sinotau Pharmaceutical Co., Ltd. subsidiary in China | Navidea Pharmaceuticals, September 4, 2014

Ricerca Biosciences in discussions to be acquired | OutsourcingPharma.com, September 3, 2014

Meridian Bioscience signs agreement with Premier to offer its hospitals molecular diagnostic tests and instruments | Business Wire, September 3, 2014

Cleveland Functional Electrical Stimulation Center taking toy donations at Expo to help disabled children | WKYC3 NBC, September 2, 2014

Aerpio Therapeutics announces publication of preclinical data on AKB-9778 for common eye diseases | Business Wire, September 2, 2014